HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

Third quarter earnings per share will be approximately 25, compared to 36 in the third quarter of 1993, the company says, due to "slower than expected sales growth in the Revitalizing brand, coupled with the continuing trend of retailer inventory reduction." The company says that the factors may also lead to full-year 1994 earnings per share dropping below 1993's year-end figure of $1.25 per share. Maybelline attributes slow Revitalizing sales to display reconfigurations at the retail level that took two to three months longer than anticipated. To compensate, the company plans to add promotional support with couponing and other trial incentives for Revitalizing. The firm also recently launched new television and print ads for the brand. Maybelline notes that it is expanding its ongoing share repurchasing program

You may also be interested in...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Chart: Weekly Trademark Review -- Nov. 2, 2010

Weekly Trademark Review



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts